Hints and tips:
...When he took charge of GlaxoSmithKline at the start of the decade, Jean-Pierre Garnier introduced a series of smaller “centres for excellence in drug discovery” focused on types of therapy....
...Unfortunately, there are no well-accepted Alzheimer’s biomarkers, like such as cholesterol levels for heart disease or viral load for Aids....
...“You cannot do drug discovery without finding the surrogate market in diagnostics.”...
International Edition